Lantibiotic

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/31 (2006.01) A23L 1/03 (2006.01) A23L 1/29 (2006.01) A61K 9/00 (2006.01) A61K 38/16 (2006.01) A61P 31/04 (2006.01) C07K 14/315 (2006.01) C12N 1/20 (2006.01) C12N 1/21 (2006.01) C12P 21/02 (2006.01) A61K 39/09 (2006.01)

Patent

CA 2363713

This invention provides an antibacterial protein, salivaricin B. Salivaricin B is bacteriocidal with respect to, inter alia, S. pyogenes and therefore has numerous therapeutic applications. These applications include, but are not limited to, forming part of therapeutic formulations for use in treating or preventing streptococcal infections of the throat.

L'invention concerne une protéine antibactérienne, salivaricine B. Salivaricine B a une fonction bactéricide, y compris vis-à-vis de <i>S. pyogenes</i> et possède de ce fait de nombreuses applications thérapeutiques. Ces applications comprennent (mais non de façon exclusive) la création de formulations thérapeutiques utilisées dans le traitement ou la prévention des infections de la gorges par des streptocoques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lantibiotic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lantibiotic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lantibiotic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1577415

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.